K
Kinnate Biopharma
Focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically-defined cancers
About Kinnate Biopharma
Kinnate Biopharma is a biotechnology company dedicated to developing precision oncology medicines aimed at treating aggressive cancers. The company focuses on creating small molecule drug candidates that target validated oncogenic drivers, which are specific genes or proteins that cause cancer. Kinnate leverages its deep expertise in structure-based drug discovery and translational research to build a robust pipeline of targeted therapies. The company operates in the biopharmaceutical market, primarily serving patients who are in urgent need of more effective cancer treatments. Kinnate's business model revolves around the research, development, and commercialization of these novel therapeutics. Revenue is generated through the successful development and eventual sale or licensing of their drug candidates. The company is driven by a mission to inspire hope and improve the lives of cancer patients through innovative, patient-driven precision medicine.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2020
News
Open roles
Kinnate Biopharma in the San Diego ecosystem
The Kinnate Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Foresite Capital
Eshelman Ventures
OrbiMed
Nextech Invest
Vida Ventures
Series B and later4 investors entered at this stage
RA Capital Management
Venrock
Viking Global Investors
Fidelity Investments
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kinnate Biopharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kinnate Biopharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

